Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
LetterLetter to the Editor

PREDICTING THE CLEARANCE OF CYP2C9 SUBSTRATES

Karen Rowland Yeo, Eleanor M. Howgate, Geoffrey T. Tucker and Amin Rostami-Hodjegan
Drug Metabolism and Disposition December 2004, 32 (12) 1522; DOI: https://doi.org/10.1124/dmd.104.001792
Karen Rowland Yeo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eleanor M. Howgate
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoffrey T. Tucker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amin Rostami-Hodjegan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 32 no. 12 1522
DOI 
https://doi.org/10.1124/dmd.104.001792
PubMed 
15550723

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received August 6, 2004
  • Accepted September 14, 2004
  • Published online November 18, 2004.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Karen Rowland Yeo,
  2. Eleanor M. Howgate,
  3. Geoffrey T. Tucker and
  4. Amin Rostami-Hodjegan
  1. Simcyp Limited, Blades Enterprise Centre, John Street, Sheffield S2 4SU, United Kingdom (K.R.Y., E.M.H., G.T.T., A.R.-H.); and Academic Unit of Clinical Pharmacology & Therapeutics, University of Sheffield, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, United Kingdom (G.T.T., A.R.-H.) E-mail: k.r.yeo{at}simcyp.com

    Statistics from Altmetric.com

    Article usage

    Article usage: August 2017 to September 2023

    AbstractFullPdf
    Aug 20170124
    Sep 20170135
    Oct 20170102
    Nov 20170144
    Dec 20170165
    Jan 2018061
    Feb 20180105
    Mar 20180114
    Apr 2018091
    May 20180101
    Jun 20180100
    Jul 2018063
    Aug 20180101
    Sep 2018091
    Oct 20180288
    Nov 20180112
    Dec 2018020
    May 2019011
    Jun 2019002
    Aug 2019010
    Dec 2019020
    Jan 2020010
    May 2020021
    Jun 2020010
    Nov 2020011
    Jan 2021050
    Feb 2021032
    Mar 2021011
    Apr 2021010
    May 2021020
    Jun 2021020
    Jul 2021010
    Aug 2021020
    Sep 2021021
    Oct 2021032
    Nov 2021010
    Dec 2021010
    Jan 2022042
    Feb 2022021
    Mar 2022021
    Apr 2022010
    May 2022011
    Jun 2022021
    Jul 2022010
    Aug 2022041
    Sep 2022010
    Oct 2022031
    Nov 2022010
    Dec 2022010
    Jan 2023020
    Feb 2023010
    Mar 2023020
    Apr 2023010
    May 2023020
    Jun 2023010
    Jul 2023020
    Aug 2023020
    Sep 2023010

    PreviousNext
    Back to top

    In this issue

    Drug Metabolism and Disposition: 32 (12)
    Drug Metabolism and Disposition
    Vol. 32, Issue 12
    1 Dec 2004
    • Table of Contents
    • About the Cover
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Drug Metabolism & Disposition article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    PREDICTING THE CLEARANCE OF CYP2C9 SUBSTRATES
    (Your Name) has forwarded a page to you from Drug Metabolism & Disposition
    (Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    LetterLetter to the Editor

    PREDICTING THE CLEARANCE OF CYP2C9 SUBSTRATES

    Karen Rowland Yeo, Eleanor M. Howgate, Geoffrey T. Tucker and Amin Rostami-Hodjegan
    Drug Metabolism and Disposition December 1, 2004, 32 (12) 1522; DOI: https://doi.org/10.1124/dmd.104.001792

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    LetterLetter to the Editor

    PREDICTING THE CLEARANCE OF CYP2C9 SUBSTRATES

    Karen Rowland Yeo, Eleanor M. Howgate, Geoffrey T. Tucker and Amin Rostami-Hodjegan
    Drug Metabolism and Disposition December 1, 2004, 32 (12) 1522; DOI: https://doi.org/10.1124/dmd.104.001792
    Reddit logo Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Use of fub Instead of fup
      • Metabolism Pathways
      • Footnotes
      • References
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Unbound Maximum Hepatic Inlet Concentration
    • Misidentification of Bupropion Glucuronide Metabolites
    • Response to Letter to the Editor
    Show more Letters to the Editor

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About DMD
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-009X (Online)

    Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics